Erythropoietin regulates signaling pathways associated with neuroprotective events

被引:0
作者
Cornelio-Martínez Sergio
Castañeda-Arellano Rolando
机构
[1] Universidad del Valle de México,Laboratorio de Farmacología, Centro de Investigación Multidisciplinario en Salud, Departamento de Ciencias Biomédicas
[2] Escuela de Ciencias de la Salud,undefined
[3] Campus Zapopan,undefined
[4] Centro Universitario de Tonalá,undefined
[5] Universidad de Guadalajara,undefined
来源
Experimental Brain Research | 2022年 / 240卷
关键词
Erythropoietin; Erythropoietin receptor; Signaling pathway; Neuroprotection; Central nervous system; Hypoxic Inducible factor 1;
D O I
暂无
中图分类号
学科分类号
摘要
Erythropoietin is a cytokine that binds to the Erythropoietin receptor and regulates the formation of erythroid cells during erythropoiesis in the bone marrow. However, many other organs and tissues express Erythropoietin and its receptor, such as the Nervous System, which principally regulates tissue protection. In the Central Nervous System, Erythropoietin is principally expressed by astrocytes, while neurons mainly express Erythropoietin receptors. Moreover, Erythropoietin acts as a pleiotropic molecule with neuroprotective effects, and its mechanisms of signal transduction pathways are defined, and there is a growing interest in its therapeutic potential. This review focuses on the role of Erythropoietin and its relationship with HIF1, PI3/Akt, GSK3B, JAK/STAT, and MAPKs signaling pathways that leads to cell survival after injury in the Central Nervous System. Knowledge of these signaling systems comprehensively could better guide EPO treatment to restoring different SNC alterations mediated by different insults.
引用
收藏
页码:1303 / 1315
页数:12
相关论文
共 489 条
[1]  
Acker T(2004)Cellular oxygen sensing need in CNS function: physiological and pathological implications J Exp Biol 207 3171-3188
[2]  
Acker H(2008)The non-haematopoietic biological effects of erythropoietin Br J Haematol 141 14-31
[3]  
Arcasoy MO(2001)Chemokines and their receptors in the central nervous system Front Neuroendocrinol 22 147-184
[4]  
Bajetto A(2002)Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro Ann N Y Acad Sci 973 60-69
[5]  
Bonavia R(1999)A potential role for erythropoietin in focal permanent cerebral ischemia in mice J Cereb Blood Flow Metab 19 643-651
[6]  
Barbero S(2000)Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain Glia 30 271-278
[7]  
Florio T(2001)Activation of the transcription factor NF-kappaB by the erythropoietin receptor: structural requirements and biological significance Cell Signal 13 673-681
[8]  
Schettini G(2014)The MAPK pathway across different malignancies: a new perspective Cancer 120 3446-3456
[9]  
Barbero S(2014)Activity increase in EpoR and Epo expression by intra-nasal recombinant human erythropoietin (rhEpo) administration in ischemic hippocampi of adult rats Neurosci Lett 583 16-20
[10]  
Bajetto A(2014)HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice J Neurochem 131 177-189